Showing items 101–200
Anti-CD27 antibodies
Grant US-10556957-B2
United States of America
MUSCARINIC ACETYLCHOLINE RECEPTOR BINDING AGENTS AND USES THEREOF
Application EP-3590578-A1
European Patent Office
Chimeric antigen receptor using antigen recognition domains derived from cartilaginous…
Application US-10526406-B2
United States of America
Process and methods for efficient manufacturing of highly pure asymmetric antibodies in…
Grant US-10508154-B2
United States of America
Stable heterodimeric antibody design with mutations in the Fc domain
Grant US-10457742-B2
United States of America
Protein binding domains stabilizing functional conformational states of GPCRs and uses…
Grant US-10436796-B2
United States of America
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
Grant US-10428119-B2
United States of America
CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
Application US-10385134-B2
United States of America
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
Application WO-2019155041-A1
World Intellectual Property Organisation (WIPO)
Antimicrobial compositions comprising single domain antibodies and pseudomonas exotoxin
Grant US-10376596-B2
United States of America
Single domain antibodies capable of modulating BACE activity
Application US-10377834-B2
United States of America
Single domain antibodies directed against ebola virus VP24
Application US-10369223-B2
United States of America
vNAR recombinant monoclonal antibodies that neutralize vascular endophelial growth factor…
Application US-10370442-B2
United States of America
Product and method for treating sarcopenia
Grant US-10358502-B2
United States of America
Selective removal of age-modified cells for treatment of atherosclerosis
Grant US-10226531-B2
United States of America
Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
Application US-10214588-B2
United States of America
Single domain antibodies directed against human immunodeficiency virus
Application US-10195277-B2
United States of America
INSECT-CONTROLLING POLYPEPTIDES AND METHODS
Application EP-3415010-A1
European Patent Office
TARGETED MODIFIED IL-1 FAMILY MEMBERS
Application EP-3022226-B1
European Patent Office
Method of producing secretable antibodies by expression in saccharomyces cerevisiae
Grant US-10138477-B2
United States of America
Methods for treating rheumatoid arthritis by administering interleukin-6 receptor…
Grant US-10138302-B2
United States of America
Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies
Grant US-10118967-B2
United States of America
Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid…
Grant US-10112987-B2
United States of America
Pseudomonas exotoxin A with less immunogenic B cell epitopes
Grant US-10111927-B2
United States of America
Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain…
Grant US-10112988-B2
United States of America
Protein binding domains stabilizing functional conformational states of GPCRs and uses…
Grant US-10078088-B2
United States of America
Screening and engineering method of super-stable immunoglobulin variable domains and…
Grant US-10078085-B2
United States of America
Pseudomonas aeruginosa PCRV binding single variable domain antibodies
Grant US-10072098-B2
United States of America
Protein binding domains stabilizing functional conformational states of GPCRs and uses…
Grant US-10054598-B2
United States of America
Antimicrobial compositions comprising single domain antibodies and pseudomonas exotoxin
Grant US-10010625-B2
United States of America
Crystal structures of heterodimeric Fc domains
Grant US-9988460-B2
United States of America
Targeted modified IL-1 family members
Application US-9932409-B2
United States of America
Targeting of interleukin-1 and -18 signaling in treatment of septic shock
Grant US-9919048-B2
United States of America
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
Grant US-9914785-B2
United States of America
Single domain antibodies capable of modulating BACE activity
Application US-9908943-B2
United States of America
Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin…
Grant US-9890369-B2
United States of America
SINGLE-DOMAIN ANTIBODIES TO EBOLA VIRUS GP PROTEIN FOR IMMUNOTHERAPY OF EBOLA FEVER
Application RU-2644202-C2
Russian Federation
CX3CR1-binding polypeptides
N/A MD-4548-B1
Republic of Moldova
Single domain antibodies as inhibitors of PCSK9
Grant US-9879093-B2
United States of America
Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin A
Grant US-9879090-B2
United States of America
Protein binding domains stabilizing functional conformational states of GPCRS and uses…
Grant US-9863959-B2
United States of America
Single domain antibodies directed against intracellular antigens
Grant US-9850321-B2
United States of America
Single variable domain antibodies against OX40L, constructs and therapeutic use
Grant US-9834611-B2
United States of America
CX3CR1-BINDING POLYPEPTIDES
Application EA-028183-B1
Eurasian Patent Organisation
CX3CR1-binding polypeptides
Grant US-9783612-B2
United States of America
Clostridium difficile-specific antibodies and uses thereof
Grant US-9771416-B2
United States of America
ANTI-ANTITHROMBIN SINGLE-DOMAIN ANTIBODIES AND POLYPEPTIDES COMPRISING THEREOF
Application WO-2017158176-A1
World Intellectual Property Organisation (WIPO)
Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes
Grant US-9765123-B2
United States of America
CD20 BINDING AGENTS AND USES THEREOF
Application WO-2017153345-A1
World Intellectual Property Organisation (WIPO)
CD20 BINDING SINGLE DOMAIN ANTIBODIES
Application WO-2017153402-A1
World Intellectual Property Organisation (WIPO)
Cx3cr1-binding polypeptides
Application TW-I598361-B
Chinese Taipei
Crystal structures of heterodimeric Fc domains
Grant US-9732155-B2
United States of America
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
Grant US-9725522-B2
United States of America
Single domain antibodies directed against STAT3
Grant US-9695234-B2
United States of America
Protein binding domains stabilizing functional conformational states of GPCRs and uses…
Grant US-9689872-B2
United States of America
Polynucleotides encoding VHNAR anti-cytokine domains
Grant US-9683035-B2
United States of America
Enhancement of transport of therapeutic molecules across the blood brain barrier
Grant US-9676849-B2
United States of America
Single domain antibodies directed against KRAS
Grant US-9663570-B2
United States of America
Human domain antibodies against components of the human insulin-like growth factor (IGF…
Grant US-9657096-B2
United States of America
Pseudomonas exotoxin A with less immunogenic B cell epitopes
Grant US-9657066-B2
United States of America
Methods for blocking or reducing binding of interleukin-6 to interleukin-6 receptor
Grant US-9617341-B2
United States of America
Interleukin-6 receptor binding polypeptides
Grant US-9611326-B2
United States of America
ANTI-TGFbeta TYPE II RECEPTOR SINGLE DOMAIN ANTIBODIES
Application EA-026097-B1
Eurasian Patent Organisation
Nucleic acids that encode interleukin-6 receptor binding polypeptides
Grant US-9605072-B2
United States of America
Stable heterodimeric antibody design with mutations in the Fc domain
Grant US-9574010-B2
United States of America
Stable heterodimeric antibody design with mutations in the Fc domain
Grant US-9562109-B2
United States of America
Single domain antibodies directed against TNF-alpha
Grant US-9546211-B2
United States of America
Amino acid sequences directed against RANK-L and polypeptides comprising the same for the…
Grant US-9534055-B2
United States of America
Inhibition of bone resorption with RANKL binding peptides
Grant US-9505840-B2
United States of America
Process and methods for efficient manufacturing of highly pure asymmetric antibodies in…
Grant US-9499634-B2
United States of America
Compositions and methods for simultaneous bivalent and monovalent co-engagement of…
Grant US-9493578-B2
United States of America
Amino acid sequences directed against RANK-L and polypeptides comprising the same for the…
Grant US-9475877-B2
United States of America
Nanoantibodies, binding Chlamydia trachomatis antigen, method for inhibition of infection…
Grant US-9464132-B2
United States of America
Highly concentrated aqueous protein solution with reduced viscosity
Grant US-9457089-B2
United States of America
Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides
Grant US-9458235-B2
United States of America
Protein binding domains stabilizing functional conformational states of GPCRs and uses…
Grant US-9453065-B2
United States of America
Pharmaceutical composition for treating ischemic events
Application US-9439961-B2
United States of America
SINGLE DOMAIN ANTIBODIES CAPABLE OF MODULATING BACE ACTIVITY
Application US-20160237166-A9
United States of America
VHNAR anti-cytokine domains
Grant US-9399677-B2
United States of America
Modified Pseudomonas exotoxin A
Grant US-9388222-B2
United States of America
CX3CR1-TARGETING IMAGING AGENTS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF DISEASE
Application EP-3035970-A1
European Patent Office
Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
Grant US-9371381-B2
United States of America
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
Grant US-9346859-B2
United States of America
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
Grant US-9320792-B2
United States of America
Novel EGFR-Binding Molecules and Immunoconjugates Thereof
Application US-20160060345-A1
United States of America
Methods of using IL-6R antibodies to block or reduce binding of IL-6 to IL-6R
Grant US-9273150-B2
United States of America
Human monoclonal antibody against S. aureus derived alpha-toxin and its use in treating…
Grant US-9249215-B2
United States of America
Polypeptide constructs including VHH directed against EGFR for intracellular delivery
Grant US-9243065-B2
United States of America
Pseudomonas exotoxin A with less immunogenic B cell epitopes
Grant US-9206240-B2
United States of America
VNAR RECOMBINANT MONOCLONAL ANTIBODIES THAT NEUTRALIZE VASCULAR ENDOPHELIAL GROWTH FACTOR…
Application WO-2015158937-A1
World Intellectual Property Organisation (WIPO)
ANTIMICROBIAL COMPOSITIONS COMPRISING SINGLE DOMAIN ANTIBODIES AND PSEUDOMONAS EXOTOXIN
Application WO-2015103479-A1
World Intellectual Property Organisation (WIPO)
Human domain antibodies against components of the human insulin-like growth factor (IGF…
Grant US-9056907-B2
United States of America
CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
Grant US-9035029-B2
United States of America
Methods of degrading or inhibiting botulinum neurotoxin using designer ubiquitin ligases
Grant US-9028813-B2
United States of America
Anti IL-6R polypeptides and compositions thereof
Grant US-8962805-B2
United States of America
Single variable domain antibodies against OX40L, constructs and therapeutic use
Grant US-8962807-B2
United States of America
Pseudomonas exotoxin a with reduced immunogenicity
Grant US-8936792-B2
United States of America
MUSCARINIC ACETYLCHOLINE RECEPTOR BINDING AGENTS AND USES THEREOF
Application WO-2014122183-A1
World Intellectual Property Organisation (WIPO)
Anti-IL-6R polypeptides and pharmaceutical compositions thereof
Grant US-8748581-B2
United States of America
Showing items 101–200